Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 13, 2004. The report details specific corporate actions regarding share repurchases and updates on directors' interests in company securities.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes and equity transactions.
- Share Repurchase Price: 1,168.31 pence per share.
- Share Reward Plan Price: £11.70 per share.
- US Retirement Fund ADR Price: $44.55 average.
- Treasury Shares Held: 63,448,000 (post-repurchase).
- Shares in Issue: 5,875,398,193 (excluding Treasury shares).
Material Changes
The primary material change reported is the reduction of outstanding shares through a treasury buyback and adjustments to directors' holdings via employee plans.
- Treasury Purchase: On December 10, 2004, the Company purchased 500,000 ordinary shares to be held in Treasury.
- Director Acquisition: Director Mr. J D Coombe acquired 22 ordinary shares (11 personal, 11 company match) under the ShareReward Plan on December 9, 2004.
- Retirement Fund Movement: The GlaxoSmithKline US Retirement Savings Plan saw a decrease in held ADRs from 18,841,944 to 18,743,733 due to fund movements on December 9, 2004.
- Trust Transfer: The GSK Trust transferred 4,932 ordinary shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a statutory disclosure of specific equity transactions.
Investor Verification Checklist
- Verify the total cost of the 500,000 share repurchase against the stated price of 1,168.31 pence.
- Confirm the updated total share count (5,875,398,193) in subsequent filings.
- Review the impact of the US Retirement Savings Plan ADR reduction on potential director interests for Dr. J P Garnier and Dr. T Yamada.
- Check the status of the SmithKline Beecham Employee Share Option Plan 1991 regarding the 4,932 shares transferred.